BioAegis Therapeutics
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6 E Cove Ln, Morristown, New Jersey, 079...Phone Number
(973) 539-4552Website
www.bioaegistherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About BioAegis Therapeutics
BioAegis Theraputics is a clinical stage private company focused on developing immunotherapy treatment and therapies for infectious, inflammatory and degenerative diseases. The company collaborates with institutions globally, and is based in Morristown, NJ.Explore more
BioAegis Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioAegis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if BioAegis Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioAegis Therapeutics
BioAegis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioAegis Therapeutics has new funding data
Earning: See what the market has to say on BioAegis Therapeutics recently announced quarterly report
Product Launch: Get notified when BioAegis Therapeutics launches new products
Check if BioAegis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if BioAegis Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined BioAegis Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to BioAegis Therapeutics
Compare insights from companies similar to BioAegis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2012
MG
Magali Gary-BoboDirector, Cnrs Research & Co-Founder & Scientific of Nanomedsyn Advisor
Company Profile Activity
Activity Insights
BioAegis Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioAegis Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioAegis Therapeutics.
BioAegis Therapeutics financials insights
Gather financial insights about BioAegis Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Debt
$8M
2016
Private Equity
$1.5M
2020
Debt
$150K
Share Placement
$5M
2021
Debt
$190K
BioAegis Therapeutics Tech Stack
A closer look at the technologies used by BioAegis Therapeutics
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
BioAegis Therapeutics has received an SBA PPP loan in the amount of $190,300 from 1st Colonial Community Bank resulting in the retention of 10 jobs.
Funding
Funding
BioAegis Therapeutics News & Media
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
Collaboration aims to identify biological signatures and patient subpopulations most likely to benefit from BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases Collaboration aims to identify biological signatures and patient subpopulations most likely to benefit from BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseasesBioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)
Fast Track status accelerates regulatory pathway for BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases.BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases.BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)
Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioAegis Therapeutics
Sign Up For FreeTo access detailed company insights
BioAegis Theraputics is a clinical stage private company focused on developing immunotherapy treatment and therapies for infectious, inflammatory and degenerative diseases. The company collaborates with institutions globally, and is based in Morristown, NJ.... Read More
